MOG and myeloid sarcoma: Consequently, patients with MOG antibodies came to be recognized as belonging to a group with inflammatory demyelinating conditions distinct from MS, and the international diagnostic criteria of MOG antibody-associated disease (MOGAD) were recently published (29).